C. Marot

发表

Comparative Molecular Field Analysis of Selective Cyclooxygenase‐2 (COX‐2) Inhibitors

D. Lesieur, C. Marot, P. Chavatte, 2000 .

Optimization and validation of a docking-scoring protocol; application to virtual screening for COX-2 inhibitors.

Luc Morin-Allory, Philippe Bernard, Jean-Christophe Mozziconacci, 2005, Journal of medicinal chemistry.

A Restrained Molecular Dynamics Empirical Approach for Generating a Small Set of Structures Representative of the Internal Flexibility of a Receptor

C. Marot, Samia Aci-Sèche, L. Morin-Allory, 2009 .

2D QSAR Consensus Prediction for High‐Throughput Virtual Screening. An Application to COX‐2 Inhibition Modeling and Screening of the NCI Database.

Luc Morin-Allory, Philippe Chavatte, Jean-Christophe Mozziconacci, 2004 .

Synthesis of novel fused tricyclic quinolones: 4a,5-Dihydro-1H-[1;2,4]triazino[1,6-a]quinoline-2,4,6(3H)-triones

C. Marot, J. Chenault, D. Edmont, 2002 .

Heuristic Statistical Analysis of Fluorescence Fluctuation Data with Bright Spikes: Application to Ligand Binding to the Human Serotonin Receptor Expressed in Escherichia coli Cells

Jo Vercammen, Jan Beirlant, Yves Engelborghs, 2001, Biological chemistry.

Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.

D. Lesieur, C. Marot, P. Chavatte, 2001, Journal of medicinal chemistry.

Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids.

C. Marot, P. Toto, J. Chenault, 2002, Bioorganic & medicinal chemistry letters.

3-amino-3,4-dihydro-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 2. Synthesis and quantitative structure-activity relationship studies of spiro[pyrrolidine- and piperidine-2,3'(2'H)-benzopyrans].

P. Renard, M. Rettori, D. Caignard, 1996, Journal of medicinal chemistry.

3D-QSAR CoMFA study on imidazolinergic I(2) ligands: a significant model through a combined exploration of structural diversity and methodology.

L Morin-Allory, P. Renard, C. Marot, 2000, Journal of medicinal chemistry.

Synthesis, biological activity and quantitative structure-activity relationships of N-substituted-3,4-dihydro-2H-1-benzopyran derivatives

M. Rettori, B. Pfeiffer, C. Marot, 1996 .

Chemistry Prospects of new Sugar-Derived Vinyl Sulfones

C. Marot, P. Rollin, 1994 .

Novel approach to the synthesis of chiral oxacyles via ring closure of sugar-derived vinyl sulfones

C. Marot, P. Rollin, 1994 .

Novel approach to the synthesis of sugar sulfones via trans-sulfonylation of a unique heteroaryl precursor

C. Marot, P. Rollin, C. Lorin, 1995 .

Preparation of (5R)-5-vinyloxazolidme-2-thione from natural epiprogoitrin using immobilized myrosinase

O. Leoni, C. Marot, S. Palmieri, 1994 .

Preparation of (5R)‐5‐Vinyloxazolidine‐2‐thione from Natural Epi‐ Progoitrin Using Immobilized Myrosinase.

O. Leoni, C. Marot, S. Palmieri, 1994 .

Unexpected heteroatom-assisted C-4 alkylation of a 1,3-dioxolane

C. Marot, P. Rollin, C. Philipp, 1992 .

Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors.

K. Berka, C. Marot, V. Kryštof, 2016, European journal of medicinal chemistry.

2D QSAR Consensus Prediction for High-Throughput Virtual Screening. An Application to COX-2 Inhibition Modeling and Screening of the NCI Database

Luc Morin-Allory, Philippe Chavatte, Jean-Christophe Mozziconacci, 2004, J. Chem. Inf. Model..

Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors.

L Morin-Allory, D. Lesieur, P. Renard, 1998, Journal of medicinal chemistry.

Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers

Alban Arrault, Luc Morin-Allory, Aurélien Monge, 2006, Molecular Diversity.

Ligand-escape pathways from the ligand-binding domain of PPARγ receptor as probed by molecular dynamics simulations

N. Garnier, C. Marot, A. Arrault, 2008, European Biophysics Journal.

[Melatonin, a pertinent prototype for therapeutic innovation].

D. Lesieur, P. Renard, C. Marot, 1998, Therapie.